348 results
Coronary artery disease and TAVI
18 May 2022 – From EuroPCR 2022
What are the need and possibilities for access to the coronary arteries after TAVI procedure? How can commissural alignment be achieved to facilitate access to the coronary arteries after TAVI procedure? And how to access coronaries arteries through a stent framework? Find some answers in this EuroPCR...
New tools and techniques in coronary lesion assessment
17 May 2022 – From EuroPCR 2022
Consult this session to learn about new tools and techniques in coronary lesion assessment, such as: the ability of near infra-red spectroscopy to identify vulnerable patients and plaques, the iFR value impact on left internal mammary artery graft patency, the FFR-guided stent optimisation in focal and diffuse coronary...
PCR's Got Talent - Round 1 - Session 1
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: DAPT modulation after PCI for ACS, plaque burden assessment from OCT with deep learning, prognosis of myocardial infarction in patients with cancer, and much more!
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery
03 Apr 2022
Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Pre-treatment with P2Y12 inhibitors in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a report from the Swedish Coronary Angiography and Angioplasty Registry
11 Mar 2022
The optimal timing of the administration of P2Y12 inhibitors in patients with CCS undergoing ad-hoc PCI is unknown. This study aimed to provide observational data to clarify these quandaries.
Reviewer
Reviewer
Risk of cardiovascular hospital admission after exposure to fine particulate pollution
23 Feb 2022
This current study explored the effect of heavy particle pollution on total cardiovascular admissions, whilst also looking at risk for specific cardiovascular diagnoses, such as angina, myocardial infarction, and ischaemic stroke.
Reviewer
Reviewer
One-year outcomes of blinded physiological assessment of residual ischemia after successful PCI - DEFINE PCI trial
10 Feb 2022
The objective of this analysis was to evaluate the impact of residual ischemia detected by post-PCI iFR on clinical outcomes and on residual-angina at the 12-month follow-up of the DEFINE PCI study.
Reviewer
Reviewer
